Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Quality Index
Jiangsu Hualv Biological Technology Co.Ltd. cash flow quality index. Jiangsu Hualv Biological Technology Co.Ltd. (300970) has a Cash Flow Quality Index of 3.13x as of December 2025. Operating cash flow of CN¥345.31 Million exceeds net income of CN¥110.27 Million, indicating high earnings quality where cash backs reported profits. See Jiangsu Hualv Biological Technology Co.L leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Jiangsu Hualv Biological Technology Co.Ltd. (2019–2025)
Cash flow quality index of Jiangsu Hualv Biological Technology Co.Ltd. from 2019 to 2025. Historical Cash Flow Quality Index for Jiangsu Hualv Biological Technology Co.Ltd. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Jiangsu Hualv Biological Technology Co.L (300970) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Jiangsu Hualv Biological Technology Co.Ltd. Cash Flow Quality Index by Year (2019–2025)
Jiangsu Hualv Biological Technology Co.Ltd. cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Jiangsu Hualv Biological Technology Co.Ltd.. For the full cash flow conversion analysis, see 300970 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.13x | CN¥345.31 Million | CN¥110.27 Million | ▼ -43.0% |
| 2023 | 5.49x | CN¥166.67 Million | CN¥30.35 Million | ▲ +139.0% |
| 2022 | 2.30x | CN¥179.84 Million | CN¥78.25 Million | ▼ -57.1% |
| 2021 | 5.36x | CN¥83.08 Million | CN¥15.50 Million | ▲ +256.6% |
| 2020 | 1.50x | CN¥199.09 Million | CN¥132.50 Million | ▼ -15.3% |
| 2019 | 1.77x | CN¥213.96 Million | CN¥120.67 Million | — |